rxstat › Shortages › Nabilone

Nabilone shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Nabilone has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 13
Reports on file
56

Reports by product

Discontinued
CESAMET
0.25MG · CAPSULE · BAUSCH HEALTH, CANADA INC.
DIN 02312263
Resolved
TEVA-NABILONE
1.0MG · CAPSULE · TEVA CANADA LIMITED
DIN 02384892 · ended Apr 22, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02392925 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02392925 · ended Aug 27, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
1.0MG · CAPSULE · TEVA CANADA LIMITED
DIN 02384892 · ended May 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02392925 · ended Jan 20, 2025 · Disruption of the manufacture of the drug.
Resolved
CESAMET
0.25MG · CAPSULE · BAUSCH HEALTH, CANADA INC.
DIN 02312263 · ended Jul 9, 2023 · Other (Please describe in comments)
Resolved
TEVA-NABILONE
1.0MG · CAPSULE · TEVA CANADA LIMITED
DIN 02384892 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02392925 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02384884 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.5MG · CAPSULE · TEVA CANADA LIMITED
DIN 02384884 · ended Apr 20, 2022 · Disruption of the manufacture of the drug.
Resolved
TEVA-NABILONE
0.25MG · CAPSULE · TEVA CANADA LIMITED
DIN 02392925 · ended Nov 30, 2021 · Disruption of the manufacture of the drug.

Showing 12 of 56 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Nabilone. Health Canada has 56 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Nabilone is classified under “ANTIEMETICS AND ANTINAUSEANTS” (ATC A04AD).

Recent changes

Common questions

When will Nabilone be back in stock in Canada?

Nabilone has no active shortage; supply is normal per Health Canada reports.

Why is Nabilone in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (antiemetics and antinauseants)

Widespread shortageGranisetron2 of 2 reported products affected · est. return Jul 24, 2026Partial shortageOndansetron11 of 54 reported products affected · est. return Oct 30, 2026Partial shortagePalonosetron1 of 2 reported products affectedDiscontinuedAprepitant0 of 2 reported products affectedDiscontinuedAprepitant Aprepitant0 of 1 reported products affectedShortage anticipatedFosaprepitant0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.